Acadia Healthcare Company, Inc.ACHCNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +4.23% | +0.32% | +9.19% | +4.41% | +6.10% |
| Gross Profit Growth | +337.12% | +43.87% | +340.71% | +4.47% | -87.13% |
| EBITDA Growth | -32.92% | -45.09% | -21.87% | -25.32% | -1108.84% |
| Operating Income Growth | -17.26% | -89.55% | -0.29% | -18.80% | -53.95% |
| Net Income Growth | -43.50% | -89.04% | -61.61% | -46.80% | -3710.36% |
| EPS Growth | -42.86% | -89.29% | -61.63% | -45.95% | -3716.67% |
| EPS Diluted Growth | -44.44% | -89.16% | -61.18% | -45.95% | -3820.00% |
| Weighted Average Shares Growth | +0.58% | +0.32% | -1.42% | -1.42% | -1.45% |
| Weighted Average Shares Diluted Growth | +0.12% | +0.03% | -1.75% | -1.74% | -1.68% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.34% | +0.00% | -21.99% | -55.12% | -173.94% |
| Free Cash Flow Growth | +0.00% | +0.00% | -302.55% | +0.00% | +0.00% |
| Receivables Growth | -1.76% | -0.65% | -4.24% | +2.79% | +4.41% |
| Inventory Growth | +6.68% | -0.61% | -2.86% | +13.29% | -100.00% |
| Asset Growth | +11.16% | +11.43% | +11.10% | +9.24% | -7.21% |
| Book Value per Share Growth | +9.85% | +5.79% | +5.74% | +4.42% | -35.66% |
| Debt Growth | +38.03% | +17.16% | +20.87% | +20.74% | +26.75% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +964.41% | +0.04% | +971.78% | +7.43% | -90.03% |